The circadian-melatonin axis in breast cancer metastasis: molecular mechanisms, organ-specific metastatic niches, and therapeutic opportunities.

Wang CH, Chong KH, Cheng CF, Chang YJ, Tsai KW

Open source

DOI
10.3389/fendo.2026.1941609
Published
2026
Container
Frontiers in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1941609,
  title = {The circadian-melatonin axis in breast cancer metastasis: molecular mechanisms, organ-specific metastatic niches, and therapeutic opportunities.},
  author = {Wang CH and Chong KH and Cheng CF and Chang YJ and Tsai KW},
  year = {2026},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2026.1941609},
  url = {https://doi.org/10.3389/fendo.2026.1941609}
}

RIS

TY  - JOUR
TI  - The circadian-melatonin axis in breast cancer metastasis: molecular mechanisms, organ-specific metastatic niches, and therapeutic opportunities.
AU  - Wang CH
AU  - Chong KH
AU  - Cheng CF
AU  - Chang YJ
AU  - Tsai KW
PY  - 2026
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1941609
UR  - https://doi.org/10.3389/fendo.2026.1941609
ER  - 

APA

CH, W., KH, C., CF, C., YJ, C., & KW, T. (2026). The circadian-melatonin axis in breast cancer metastasis: molecular mechanisms, organ-specific metastatic niches, and therapeutic opportunities.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1941609

Source records